Osmosis Investment Management UK Ltd Buys New Position in Humana Inc. $HUM

Key Points

• Osmosis Investment Management initiated a Humana position in the second quarter, purchasing 3,128 shares valued at approximately $1.24 million. Institutional investors collectively own 92.38% of Humana’s stock.
• Analyst sentiment is mixed but improving: Humana has a consensus “Hold” rating and an average price target of $403.91, with some firms recently upgrading the stock or raising targets.
• Humana exceeded quarterly expectations, reporting $7.61 in EPS versus $7.27 expected and $40.89 billion in revenue, up 26.2% year over year. Shares opened at $386.43, near the consensus target.

Osmosis Investment Management UK Ltd purchased a new position in Humana Inc. (NYSE:HUM - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,128 shares of the insurance provider's stock, valued at approximately $1,243,000.

A number of other large investors have also modified their holdings of the business. Revolve Wealth Partners LLC purchased a new stake in Humana during the 4th quarter worth approximately $202,000. Woodline Partners LP raised its holdings in shares of Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider's stock worth $2,697,000 after buying an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in shares of Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider's stock worth $316,000 after buying an additional 452 shares during the last quarter. Cresset Asset Management LLC lifted its stake in shares of Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider's stock worth $581,000 after buying an additional 222 shares during the period. Finally, WINTON GROUP Ltd grew its holdings in shares of Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider's stock valued at $582,000 after buying an additional 879 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Leerink Partners raised Humana from a "market perform" rating to an "outperform" rating and set a $513.00 target price on the stock in a research report on Thursday, July 30th. Morgan Stanley upgraded Humana from an "underweight" rating to an "equal weight" rating and boosted their price target for the company from $249.00 to $370.00 in a research note on Tuesday, August 4th. Robert W. Baird set a $390.00 price objective on Humana in a report on Thursday, July 30th. Jefferies Financial Group upgraded Humana from a "buy" rating to a "buy" rating in a research note on Wednesday, May 20th. Finally, Truist Financial lifted their target price on Humana from $320.00 to $415.00 and gave the stock a "hold" rating in a report on Tuesday, July 14th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Humana currently has a consensus rating of "Hold" and a consensus price target of $403.91.

Humana Stock Up 2.0%

HUM opened at $386.43 on Tuesday. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The company has a fifty day moving average of $383.50 and a two-hundred day moving average of $283.61. The stock has a market capitalization of $46.40 billion, a price-to-earnings ratio of 36.56, a PEG ratio of 2.17 and a beta of 0.72.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the company posted $6.27 EPS. The company's revenue for the quarter was up 26.2% on a year-over-year basis. On average, research analysts expect that Humana Inc. will post 9.08 earnings per share for the current year.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source